Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Fluorodeoxyglucose F18 × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Stomach Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Thyroid Neoplasms 3 Neuroendocrine Tumors 3 Neoplasms 3 Cholangiocarcinoma 3 Anus Neoplasms 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Carcinoma, Renal Cell 2

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡